HAWK is down -1.58% in premarket trading on Aug 13, slipping to about $24.34 from a $24.73 prior close. The move follows a -1.43% regular-session decline on Aug 12 and comes ahead of Q2 results due after today's close.
UAMY fell about 16.75% over the 30-day window ended with the latest available close, from $5.97 to $4.97. The decline was driven by second-quarter 2026 results released August 11: revenue of $7.9 million, down 25% year over year and below consensus expectations.
Selected price target: $80 per share, a level roughly 20% above the low-to-mid $60s range where FRDM traded in mid-August 2026. Strongest bullish factors: heavy semiconductor exposure through Samsung Electronics, SK hynix, and Taiwan Semiconductor Manufacturing Company ( TSM ), plus AI-driven memory demand.
The $400 target represents roughly 28% upside from AAPL's current level near $313, and has been formally adopted by TD Cowen and Wedbush as their base-case price objective. Apple's capital-light AI strategy —partnering with Alphabet (GOOGL) for Gemini-powered cloud AI rather than spending hundreds of billions on data centers—has become an unexpected competitive advantage as investors sour on hyperscaler capital expenditure (capex) levels.
GME closed at $18.54 on August 12, 2026, down 17.3% from its July 14, 2026 close of $22.43. The sharpest move came on August 3, when shares fell about 12% after GameStop announced a $1.4 billion convertible-note-for-equity exchange.
The selected price target is $400 per share , about 9.5% above the most recent close of $365.18 and beyond the current 52-week high of $366.09. Strongest bullish factors: record second-quarter 2026 results, surging trading and investment banking revenue, $5.1 trillion in assets under management, and solid capital returns.
Revenue rose 38% year over year to $1.124 billion, while net earnings climbed to $305 million, or $0.72 per share. Adjusted earnings per share (EPS) of $0.73 nearly doubled from $0.43 a year earlier but landed below consensus estimates.
Reported net income came in at R$1.46 billion for Q2 2026, down 31.4% year over year and just below the R$1.53 billion consensus compiled by LSEG. Total net revenue rose 13.9% to R$10.21 billion, while adjusted net revenue grew 6.7% to R$6.01 billion.
Amcor reported fiscal fourth-quarter 2026 adjusted earnings per share (EPS) of $1.23 , above the $1.19 analyst consensus, while full-year adjusted EPS rose 13% to $4.02 . Net sales increased 26% year over year to $6.4 billion , ahead of the $6.05 billion consensus, supported by the Berry Global acquisition and higher raw-material pass-through.
Nebius Group reported second-quarter 2026 revenue of $582.3 million, up 454% from $105.1 million a year earlier and above the roughly $569.9 million consensus estimate. Adjusted EBITDA swung to a positive $236.2 million from a loss of $21.0 million in the prior-year quarter.
Cisco reported record fourth-quarter fiscal 2026 revenue of $17.3 billion, up 18% year over year and above consensus estimates of roughly $16.8 billion. Adjusted earnings per share (EPS) came in at $1.22, beating the $1.17 consensus estimate by $0.05; GAAP (generally accepted accounting principles) diluted EPS was $0.97.
Coherent reported fiscal fourth-quarter revenue of $2.05 billion, up 33.8% year over year and its first quarter above the $2 billion mark. Non-GAAP (adjusted) earnings per share (EPS) reached $1.74, beating the consensus estimate of $1.62; GAAP EPS was $1.19 versus a loss of $0.83 a year earlier.
CORT (Corcept Therapeutics Incorporated) demonstrated strong recent momentum driven by robust Q2 2026 revenue growth of 32% year-over-year and upward revisions to full-year guidance. CPK (Chesapeake Utilities Corporation) has delivered steady performance typical of regulated utilities, supported by consistent earnings growth and infrastructure investments in recent quarters.
Advanced Micro Devices (AMD) has delivered substantially stronger year-to-date price performance than NVIDIA (NVDA), with gains exceeding 120% compared to NVDA’s approximately 17% advance. Both companies benefit from robust demand in artificial intelligence infrastructure, though NVDA maintains a dominant 70-80% share in the AI graphics processing unit (GPU) market.
VXX is an exchange-traded note (ETN) providing exposure to short-term VIX futures, while XXX is an exchange-traded fund (ETF) blending 75% S&P 500 equity exposure with 25% XRP futures exposure. Structural differences are significant: VXX offers pure volatility targeting with no equity holdings, whereas XXX delivers diversified large-cap equity and cryptocurrency futures exposure through a rules-based index.
Maximus, Inc. ( MMS ) operates in government services outsourcing, while TowneBank ( TOWN ) focuses on regional banking in the southeastern United States. MMS has experienced significant year-to-date declines exceeding 35%, reflecting post-earnings pressure and broader market positioning challenges in recent market activity.
Corcept Therapeutics ( CORT ) has demonstrated stronger recent momentum with substantial year-to-date gains compared to OPKO Health ( OPK ). CORT reported robust second-quarter revenue growth of 32% year-over-year, supporting positive sentiment in recent market activity.
Selected price target: $30, approximately 34.5% above the $22.30 close on August 12, 2026, and not yet reached. Strongest bullish factors: accelerating annual recurring revenue (ARR), record net-new ARR growth, an AI-native platform, and improving losses.
UiPath (PATH) is scheduled to report second quarter fiscal 2027 results after the market closes on Thursday, September 3, 2026. Wall Street consensus projects adjusted (non-GAAP) earnings per share (EPS) of about $0.15, roughly flat with $0.15 in the year-ago quarter.
Selected price target: $38 per share, roughly 87% above the August 12, 2026 close near $20.35. Bullish factors: an 11.5-gigawatt development pipeline, blue-chip partners, proprietary TRISO-X fuel technology, and a Buy-leaning analyst consensus with a $37.86 average target.